Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-11

Clinical Trial Update: Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY) [Phase 3]

View source ↗

Summary

Phase 3 MODERATO STUDY evaluating atropine eyedrops to slow myopia progression in children and adolescents is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine Eyedrops (atropine)

Snippet

Sponsor: Ocus Innovation Ireland Limited | Conditions: Myopia | Phase 3 | Status: RECRUITING